Emirates Bets Big on Boeing: $38 Billion Order for 65 Boeing 777X Jets Anchors Dubai Airshow 2025

Emirates Bets Big on Boeing: $38 Billion Order for 65 Boeing 777X Jets Anchors Dubai Airshow 2025

Dubai, United Arab Emirates — November 17, 2025: Emirates has stunned the opening day of Dubai Airshow 2025 with a new order for 65 Boeing 777‑9 aircraft, a deal valued at $38 billion at list prices and built around Boeing’s delayed but strategically crucial 777X program. The purchase lifts Emirates’ total 777X commitment to 270 aircraft and takes its overall Boeing widebody orderbook to 315 jets, including 777 freighters and 787 Dreamliners. Emirates+2MediaRoom+2 The blockbuster deal is the latest twist in the story of Boeing’s next‑generation long‑haul flagship: a jet that has accumulated huge costs and multiple delays, yet continues
17 November 2025
Deutsche Bank Stock Plunges Again as Global Credit Jitters Flare – What Experts Predict Next

Deutsche Bank Investor Day 2025: New 13% RoTE Target, €37bn Revenue Goal and 250 Wealth Manager Hires

FRANKFURT/LONDON — November 17, 2025.Deutsche Bank has kicked off a new phase of its turnaround, telling investors it aims to deliver a return on tangible equity (RoTE) of more than 13% by 2028, grow revenues to about €37bn and lift shareholder payouts to 60% of net profit — while hiring up to 250 additional wealth managers to accelerate growth. Deutsche Bank+2Reuters+2 The strategy update, unveiled at the bank’s Investor Deep Dive 2025 in London, marks the most ambitious set of financial targets since Christian Sewing took over as chief executive in 2018 and vowed to stabilise a lender hit by
Billion-Dollar Brawl: Novo Nordisk and Pfizer Clash in High-Stakes Obesity Drug Takeover

Novo Nordisk Slashes Wegovy and Ozempic Cash Prices to $349, Launches $199 Intro Deals as GLP‑1 Price War Escalates

Published November 17, 2025 Novo Nordisk moved aggressively today to cut out‑of‑pocket costs for its blockbuster GLP‑1 drugs Wegovy and Ozempic, unveiling new self‑pay prices and limited‑time offers that it says will reach tens of thousands of U.S. pharmacies and telehealth partners. The changes come just days after the Trump administration struck landmark pricing agreements with Novo Nordisk and Eli Lilly that will extend Medicare and Medicaid coverage to obesity drugs for the first time and launch a government-run discount pharmacy site, TrumpRx, in early 2026. The White House+2Reuters+2 At the same time, telehealth and discount platforms including GoodRx and
Salesforce (CRM) Stock Today: Analyst Target Cuts, AI Commerce Push and What It Means for Investors — November 17, 2025

Salesforce (CRM) Stock Today: Analyst Target Cuts, AI Commerce Push and What It Means for Investors — November 17, 2025

Salesforce (NYSE: CRM) shares spent Monday under pressure, trading around the high‑$230s to low‑$240s and finishing the session near $239 per share, roughly 1.5–1.8% lower on the day, according to intraday and historical data.Investing.com The AI‑driven CRM leader is still sitting well below its 52‑week high in the mid‑$360s, despite steadily growing revenue and earnings. At the same time, Wall Street remains broadly bullish. Bank of America and Mizuho both trimmed their price targets today but kept positive ratings, while the consensus one‑year target across major brokerages still sits in the low‑$320s — implying roughly 35–38% upside from current levels.MarketBeat+2GuruFocus+2
Kaixin Holdings (KXIN) Stock Explodes Over 100% on Heavy Volume as Traders Revisit High‑Risk AI and Crypto Bet – 17 November 2025

Kaixin Holdings (KXIN) Stock Explodes Over 100% on Heavy Volume as Traders Revisit High‑Risk AI and Crypto Bet – 17 November 2025

Kaixin Holdings (NASDAQ: KXIN) is back in the spotlight on Monday, with its stock more than doubling in volatile trade and landing among the most active names on the Nasdaq, even as the broader U.S. market trades lower. Benzinga+2Yahoo Finance+2 By late morning U.S. time on 17 November 2025, KXIN was changing hands around $0.65, up well over 100% from Friday’s close near $0.31. Different real‑time feeds show an intraday range of roughly $0.38–$0.75 and more than 180–200 million shares traded — enormous turnover for a stock whose average daily volume has recently been under 1 million shares. Investing.com+1 KXIN
LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (LFMD) Slashes Wegovy and Ozempic Cash-Pay Price to $199 as Q3 2025 Earnings and GLP‑1 Price War Heat Up

LifeMD (NASDAQ: LFMD) announced the lowest nationwide cash-pay pricing for Wegovy and Ozempic at $199 per month for new patients, just hours before its rescheduled Q3 2025 earnings release. Here’s what it means for patients, investors, and the GLP‑1 weight-loss market LifeMD Announces $199 Cash-Pay Pricing for Wegovy and Ozempic This morning, LifeMD, Inc. (NASDAQ: LFMD) unveiled what it calls the lowest cash‑pay pricing available nationwide for the GLP‑1 weight‑loss drugs Wegovy and Ozempic, in continued collaboration with Novo Nordisk. MarketScreener+3GlobeNewswire+3Quiver Quantitative+3 Under the new offer: The move builds on LifeMD’s shift away from compounded GLP‑1s toward direct partnerships with
Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

Vita Coco (COCO) Soars on Tariff Relief and BofA Upgrade as Stock Hits New High – 17 November 2025

On Monday, 17 November 2025, shares of The Vita Coco Company, Inc. (NASDAQ: COCO) surged to fresh record levels after the White House moved to exempt coconut water from new reciprocal tariffs and Bank of America (BofA) upgraded the stock to Buy with higher 2026 profit estimates.Nasdaq+2Investing.com+2 The rally caps several weeks of strong news flow for the coconut‑water leader, including robust third‑quarter results, raised full‑year guidance, and ongoing share repurchases.TradingView+2Simply Wall St+2 Key takeaways for today (17 November 2025) COCO stock price today: rally extends to record territory As of late trading on 17 November, COCO is changing hands
HPE Stock Slides on Morgan Stanley Downgrade as $714 Million H3C Sale Reshapes Its China Footprint – November 17, 2025

HPE Stock Slides on Morgan Stanley Downgrade as $714 Million H3C Sale Reshapes Its China Footprint – November 17, 2025

Hewlett Packard Enterprise (NYSE: HPE) is in the spotlight today as Wall Street reacts to a fresh analyst downgrade, a major divestment in China, and ongoing bets on AI, hybrid cloud and supercomputing. HPE shares under pressure after Morgan Stanley downgrade Hewlett Packard Enterprise started the week on the defensive as Morgan Stanley downgraded the stock to “Equal-weight” from “Overweight” and cut its price target to $25 from $28. The bank flagged what it called an “unprecedented” memory pricing cycle, with DRAM and NAND prices up roughly 50% to as much as 300% over the last six months, squeezing margins
Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Aramark (ARMK) Slides as Q4 2025 Earnings Miss, but 2026 Outlook Stays Strong

Aramark (NYSE: ARMK) reported its fiscal fourth‑quarter and full‑year 2025 results before the U.S. market opened on Monday, November 17, 2025. The numbers showed strong full‑year growth, record new business wins and a higher dividend — but a softer‑than‑expected Q4 and “lofty” expectations sent the stock lower in today’s session. Business Wire+2Investing.com Canada+2 By late afternoon, Aramark shares were trading around $35.98, down roughly 5–6% from Friday’s close, on heavy volume. The drop follows a pre‑market slide that earlier reached nearly 8% after investors digested the earnings miss and guidance. Investing.com Canada+1 At the same time, management laid out a
PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

PowerBank (SUUN) Returns to Profitability: Q1 2026 Earnings, AI Deal and Stock Reaction on 17 November 2025

Clean‑energy developer and IPP PowerBank Corporation (NASDAQ: SUUN, Cboe CA: SUNN) swings back to profit as it leans into solar, storage and AI‑driven project planning. PowerBank Corporation, the Canadian‑based solar and battery storage developer formerly known as SolarBank, reported a profitable first quarter of fiscal 2026 today and unveiled a fresh milestone in its AI partnership with Intellistake Technologies, sending the thinly traded renewable‑energy stock back into the spotlight. Powerbank Corporation+1 Q1 2026: PowerBank posts first quarterly profit since major write‑downs In a designated earnings release covering the three months ended 30 September 2025, PowerBank said it: Powerbank Corporation+1 Earnings
Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle (ALB) Soars as Lithium Prices Spike and Argus Lifts Target to $140 – What Investors Need to Know Today (17 November 2025)

Albemarle stock (NYSE: ALB) jumped around 8–9% on November 17, 2025, as lithium prices hit a one‑year high and Argus raised its price target to $140. Here’s what’s driving the move, how Wall Street is reacting, and what it could mean for investors. Albemarle stock is on fire today Albemarle stock has been in rally mode for days, but today’s move stands out even in a strong November run. German market outlet wallstreet‑online describes today’s advance as a “kräftiger Gewinn” (strong gain), pointing out that: wallstreet-online.de In other words, today is not a random pop – it’s part of a
Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

Canadian Solar (CSIQ) Stock Soars on Storage Deals, Roth Price Target Hike & Insider Sales – November 17, 2025

As of mid-afternoon on November 17, 2025, Canadian Solar Inc. (CSIQ) is trading around $29–30 per share, after an extremely volatile few sessions that saw the stock spike to the mid‑$30s following its Q3 2025 earnings release. MarketBeat 1. Stock performance: from laggard to November high‑flyer Canadian Solar has turned into one of November’s surprise momentum stories: Today’s action looks more like consolidation after a huge run: the real story on November 17 is in the newsflow around battery storage, analyst calls and insider activity, rather than another big price spike. 2. Q3 2025 earnings: revenue and margin beat, but

Stock Market Today

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Go toTop